News & Perspective

Sep 29, 2006

Sep 29, 2006

Airborne flu viruses threaten health workers, expert says

(CIDRAP News) – A microbiologist who reviewed the evidence about how influenza viruses spread says that some official guidelines, including the US pandemic influenza plan, may not go far enough in protecting healthcare workers who take care of flu patients.

Sep 28, 2006

Sep 28, 2006

1918 flu virus triggers extreme immune reaction in mice

(CIDRAP News) – A study in which mice were infected with the resurrected 1918 Spanish influenza virus has yielded fresh evidence for the view that the virus could trigger a suicidal immune response—one that has often been compared with the effects of the H5N1 avian flu virus on susceptible humans.

Sep 22, 2006

Sep 22, 2006

Mild H5 flu virus found in Montana ducks

(CIDRAP News) – Wild ducks in Montana were found to be carrying what may be an H5N1 avian influenza virus, but not the lethal Asian strain of H5N1, US officials announced yesterday.

Sep 20, 2006

Sep 20, 2006

Roche ready to make Tamiflu in US

(CIDRAP News) – Roche announced last week that its United States supply chain for oseltamivir (Tamiflu), used to treat avian influenza and seasonal flu patients, is fully operational, meaning all aspects of its production are based on US soil.

Sep 12, 2006

Sep 12, 2006

In 2001-02, reduced air travel delayed flu season

(CIDRAP News) – Researchers reported today that reduced air travel in the wake of the Sep 11, 2001, terrorist attacks delayed and prolonged that year's influenza season.

Sep 11, 2006

Sep 11, 2006

Clinical study points to cytokine storm in H5N1 cases

(CIDRAP News) – A controlled study of H5N1 influenza patients in Vietnam has provided fresh evidence that explosive viral growth and the resulting cytokine storm, or excessive immune response, account for the often lethal nature of H5N1 disease.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»